Check Cap (CHEK) Releases Earnings Results, Beats Estimates By $0.03 EPS

Share on StockTwits

Check Cap (NASDAQ:CHEK) issued its earnings results on Monday. The medical research company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.03, Fidelity Earnings reports.

Shares of CHEK opened at $3.84 on Wednesday. Check Cap has a 12-month low of $3.08 and a 12-month high of $19.78.

CHEK has been the topic of a number of recent research reports. HC Wainwright set a $14.00 target price on Check Cap and gave the stock a “buy” rating in a report on Wednesday, August 1st. Zacks Investment Research cut Check Cap from a “buy” rating to a “hold” rating in a report on Tuesday, July 24th.

ILLEGAL ACTIVITY WARNING: “Check Cap (CHEK) Releases Earnings Results, Beats Estimates By $0.03 EPS” was first published by Week Herald and is owned by of Week Herald. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at

About Check Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.

See Also: Stock Symbols Definition, Examples, Lookup

Earnings History for Check Cap (NASDAQ:CHEK)

Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with's FREE daily email newsletter.

Leave a Reply